CNTX
Context Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.24
−2.30%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.09
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.15
- EPS estimate
- -$0.09
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -19.0%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.09 | -$0.15 | Miss -62.80% | — |
| May 6, 2026 | -$0.12 | -$0.09 | Beat 25.00% | — |
| Mar 23, 2026 | -$0.11 | -$0.14 | Miss -27.27% | — |
| Nov 5, 2025 | -$0.09 | -$0.10 | Miss -11.11% | — |
| Mar 20, 2025 | -$0.05 | -$0.04 | Beat 20.00% | — |
| Mar 21, 2024 | -$0.35 | -$0.42 | Miss -20.00% | $19.0K |
| Nov 9, 2023 | -$0.30 | -$0.37 | Miss -23.33% | — |
| Mar 22, 2023 | -$0.30 | -$0.22 | Beat 26.67% | — |
| Nov 9, 2022 | -$0.25 | -$0.24 | Beat 4.00% | — |
| Aug 11, 2022 | -$0.25 | -$0.25 | In line | — |
| Mar 24, 2022 | -$0.27 | -$0.30 | Miss -12.16% | — |
| Dec 2, 2021 | — | -$4.00 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026